- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pancreatic Neuroendocrine Neoplasm in Canada
Total 7648 results
-
Thallion PharmaceuticalsTerminatedMelanomaUnited States, Canada
-
Arbor Research Collaborative for HealthRecruitingPancreatic Ductal Adenocarcinoma | Pancreas Cancer | Genetic Predisposition | Pancreas CystUnited States, Italy, Canada, Israel, Spain, United Kingdom, Iceland, Taiwan, Singapore, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
NCIC Clinical Trials GroupZymoGeneticsCompletedMelanoma (Skin)Canada
-
University of CalgaryRecruitingPancreatic Diseases | Biliary DiseaseCanada
-
Eli Lilly and CompanyARMO BioSciencesCompletedPancreatic CancerUnited States, Belgium, Spain, Poland, Korea, Republic of, Taiwan, Germany, Italy, France, United Kingdom, Austria, Australia, Canada
-
Daiichi Sankyo, Inc.CompletedPancreatic CancerUnited States, Canada, Puerto Rico
-
OSI PharmaceuticalsCanadian Cancer Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)Canada
-
NCIC Clinical Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPancreatic CarcinomaUnited States, Canada, Korea, Republic of, Puerto Rico
-
Astellas Pharma IncCompletedMelanomaUnited States, Canada
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ontario Institute for Cancer Research; Terry...RecruitingMelanoma | Lymphoma | Kidney Cancer | Leukemia | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Solid Tumor | Prostate Cancer | Pancreas Cancer | Ovary CancerCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingPancreatic Cancer | Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic AdenocarcinomaUnited States, Canada
-
University Health Network, TorontoNovartisTerminated
-
PfizerCompletedCarcinoma, Pancreatic DuctalUnited States, Netherlands, Canada, Hungary, Spain, United Kingdom, France, Austria, Belgium, Germany, Ireland, Korea, Republic of, Russian Federation, Sweden, South Africa, Italy, Singapore, Taiwan, Australia, India, Argentina, J... and more
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ontario Institute for Cancer ResearchCompletedBreast Cancer | Colorectal Cancer | Metastatic | Gynecological Cancer | Melanoma Cancer | Eligible for Phase I or Phase II StudyCanada
-
Ocellaris Pharma, Inc.RecruitingSarcoma | Neoplasms | Renal Cell Carcinoma | Cervical Cancer | Cancer | Hepatocellular Carcinoma | Gastric Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Squamous... and other conditionsCanada
-
Hoffmann-La RocheCompletedPancreatic CancerAustralia, Belgium, Germany, Hong Kong, Canada, Spain, Taiwan, Singapore, France, United Kingdom, Austria, Italy, Croatia, Serbia, Brazil, Israel, Lithuania, Poland, Greece, Argentina, Denmark, Romania, Mexico
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States, Canada
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
Southwest Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia...CompletedPancreatic CancerCanada, United States
-
University of AlbertaWithdrawnLiver Diseases | Bowel Disease | Pancreas Disease | Anesthesia; FunctionalCanada
-
Vancouver Coastal HealthUnknownNeuroblastoma | Pheochromocytoma | Paraganglioma | Medullary Thyroid Carcinoma | Carcinoid TumorsCanada
-
British Columbia Cancer AgencyRecruitingProstatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | ParagangliomaCanada
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
AmMax Bio, Inc.Merck Sharp & Dohme LLCCompletedColorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung CancerCanada, United States, Australia, Belgium, Spain, Germany
-
University of Maryland, BaltimoreEli Lilly and CompanyCompletedGastrointestinal Neoplasms | Ovarian NeoplasmsCanada, United States
-
PfizerTerminatedCarcinoma, Islet Cell | Carcinoma, PancreasUnited States, Canada, Belgium, Spain, Australia, Germany, Korea, Republic of, Taiwan, United Kingdom, France, Italy
-
Incyte CorporationTerminatedPancreatic CancerUnited States, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Korea, Republic of, Canada, New Zealand, Australia, Thailand
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
AmgenCompletedMelanomaUnited States, Canada
-
Halozyme TherapeuticsTerminatedPancreatic Ductal CarcinomaKorea, Republic of, United States, Taiwan, United Kingdom, Israel, France, Germany, Netherlands, Canada, Spain, Australia, Brazil, Belgium, Croatia, Czechia, Denmark, Estonia, Hungary, Italy, Latvia, Lithuania, Poland
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
Esperas Pharma Inc.RecruitingNeoplasms | Soft Tissue Sarcoma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Rectal Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Colon Cancer | Solid Tumors | Pancreas CancerCanada, United States, Croatia, Poland
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
National Cancer Institute (NCI)AstraZenecaActive, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Advanced Malignant Solid Neoplasm | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Stage IIIA Lung Non-Small... and other conditionsUnited States, Canada
-
Boehringer IngelheimRecruitingColorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal NeoplasmsUnited States, Canada
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedMetastatic Adenocarcinoma of the Pancreas | Germline BRCA1/2 Mutations andUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Germany, Korea, Republic of, Australia, Israel, Netherlands
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed